Mutation pattern of AML cases with intermediate and unfavorable cytogenetics. Distributions and frequencies are given for aberrations in TP53, NPM1, CEBPA, MLL-PTD, ASXL1, RUNX1, and FLT3-ITD. The patient cohort is further annotated according to cytogenetics. Cases with favorable risk cytogenetics were not included, as not all molecular markers were analyzed in all cases of this subset because the hierarchical model prognostic assignment was based on the detection of the specific fusion transcript irrespective of further mutations.